TNFSF11 and Miyoshi myopathy: Interestingly, while MM patients showed increased -median (range)- IL6 −21 (0–133) pg/mL-, BALP −484 (200–1352) ng/mL- and RANKL −985 (498–4246) pg/mL- levels in plasma, these three later markers were within the normal range in plasma of both SMM −1.2 (0.08–9) pg/mL, 159 (29–366) ng/mL and 453 (109–858) pg/mL vs. 2.5 (0–22) pg/mL, 173 (120–316) ng/mL and 580 (547–1082) pg/mL in HD, respectively (p > 0.05)- and MGUS (Figure 4A–G).